| dc.description.abstract | Gliomas are brain tumors that are extremely difficult to diagnose and treat. While we have
learned a lot about gliomas, we do not fully understand how they develop and progress. This lack
of information makes it difficult to determine the appropriate treatment. The study analyzed how
codons are used in the glioma genome to understand how the disease progresses. Our results
show that there is a clear codon bias towards GC-rich sequences, especially in the third codon
region (GC3), compared to typical network patterns. The similarity of these codons to common
human tRNAs suggests that translational selection, which can be driven by tumor-specific
factors, plays an important role in determining codon function in gliomas. In addition, this study
also found abnormal arginine codon usage, which may indicate alterations in important signaling
pathways required to support tumor growth and survival. These findings reveal molecular
alterations in gliomas and pave the way for novel diagnostic markers and therapeutic approaches.
Understanding how codons are used in gliomas may help improve strategies to address
tumor-unique mechanisms, opening new avenues for tailored treatments. | en_US |
